SAWAF AZIZ (SVP & CHIEF FINANCIAL OFFICER) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/22/2024ACC: 0001415889-24-027571
Officer· SVP & CHIEF FINANCIAL OFFICER
Since Feb 2026
-8.48K
Net shares
Net seller
$84.5K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
8.48K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−8.48K
Price / share
$9.97
Trade value
$84.52K
% of position
2.6%
11/20/2024
321.37K→312.89K
Total
Net shares
−8.48K
Net value
-$84.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 11/20/2024 | F · Tax Withholding | −8.48K | $9.97 | $84.52K | 2.6% | 321.37K | 312.89K |
| Total | −8.48K | -$84.52K | ||||||
Derivative Transactions0
No derivative transactions reported